<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04037384</url>
  </required_header>
  <id_info>
    <org_study_id>UMagdeburg</org_study_id>
    <nct_id>NCT04037384</nct_id>
  </id_info>
  <brief_title>Training of Eye Movements in Glaucoma</brief_title>
  <acronym>EyeYoga</acronym>
  <official_title>Alternative Home Training Possibilities for Glaucoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Magdeburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Magdeburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the trial is to investigate the possibilities of improving visual impairments with&#xD;
      eye training exercises (eye-yoga) in a total of 40 patients with glaucoma who have not&#xD;
      previously been treated within a similar training program. 20 patients will be instructed how&#xD;
      to do eye yoga to be performed dails for 4 weeks (max 30 min/day). As a control group of 20&#xD;
      patients will be instructed to read for 30 min/day for 4 weeks.&#xD;
&#xD;
      The following outcome measures will be investigated: High Resolution Perimetry, Humphrey&#xD;
      Perimetry, Visual Acuity Test, Contrast Sensitivity Test, Microsaccades measurements,&#xD;
      Intraocular Pressure Measurement, Electroencephalogram (EEG), Blood Pressure and Pulse&#xD;
      Measurement and Dynamic Vessel Analysis (DVA - the blood supply in the eye (especially&#xD;
      vascular dysregulation) .&#xD;
&#xD;
      Furthermore, factors that could influence response variability and the effectiveness of&#xD;
      treatment will be analysed: (i) the role of mental stress (or stress resilience) and (ii) the&#xD;
      influence of personality traits and quality of life.&#xD;
&#xD;
      The study is intended to further validate this home training program (eye yoga) for the&#xD;
      treatment of visual impairment in glaucoma.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of eye yoga is to improve microsaccade impairments in patient with primary open angle&#xD;
      glaucoma. We will study how this affects visual performance and the physiology of the eye and&#xD;
      brain&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual field size determined by perimetry measurements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes of the visual field's size, evaluated by static perimetry and high resolution perimetry measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microsaccade measurements</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in the deviation of eye movements when visual targets are followed, using a computerized test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood circulation in the eye</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes of the diameter of blood vessels in the eye, measured by vessel analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EEG connectivities</measure>
    <time_frame>4 weeks</time_frame>
    <description>Changes in alpha power using EEG recording (128 channels)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Glaucoma</condition>
  <condition>Eye Yoga</condition>
  <arm_group>
    <arm_group_label>Eye Yoga group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eye yoga exercises</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reading Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Passive reading</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Eye yoga</intervention_name>
    <description>Eye yoga exercises at home given by a trained instructor</description>
    <arm_group_label>Reading Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Passive Reading</intervention_name>
    <description>Passive reading at home</description>
    <arm_group_label>Eye Yoga group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinical diagnosis of glaucoma&#xD;
&#xD;
          -  residual vision&#xD;
&#xD;
          -  the duration of the disease must be at least 6 months old&#xD;
&#xD;
          -  the visual field defect must be stable&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  autoimmune diseases in the acute stage&#xD;
&#xD;
          -  neurological and mental diseases&#xD;
&#xD;
          -  diabetic retinopathy&#xD;
&#xD;
          -  addictions&#xD;
&#xD;
          -  hypertension (maximum 160/100 mmHg)&#xD;
&#xD;
          -  retinitis pigmentosa-&#xD;
&#xD;
          -  pathological nystagmus&#xD;
&#xD;
          -  non-distant tumors or recurrent tumors&#xD;
&#xD;
          -  photosensitivity&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard A Sabel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Magdeburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bernhard A Sabel, PhD</last_name>
    <phone>+491732540612</phone>
    <email>bernhard.sabel@med.ovgu.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inst. of Medical Psychology, Univ. of Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Sabel, Prof. Dr.</last_name>
      <phone>0049 (0)3916721</phone>
      <phone_ext>800</phone_ext>
      <email>bernhard.sabel@med.ovgu.de</email>
    </contact>
    <investigator>
      <last_name>Bernhard Sabel, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Medical Psychology</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard A Sabel, Prof.</last_name>
      <phone>+ 49 391 67 21 800</phone>
      <email>bernhard.sabel@med.ovgu.de</email>
    </contact>
    <contact_backup>
      <last_name>Sylvia Prilloff, PhD</last_name>
      <phone>+ 49 391 67 21 807</phone>
      <email>sylvia.prilloff@med.ovgu.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Dada T, Mittal D, Mohanty K, Faiq MA, Bhat MA, Yadav RK, Sihota R, Sidhu T, Velpandian T, Kalaivani M, Pandey RM, Gao Y, Sabel BA, Dada R. Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma: A Randomized Controlled Trial. J Glaucoma. 2018 Dec;27(12):1061-1067. doi: 10.1097/IJG.0000000000001088.</citation>
    <PMID>30256277</PMID>
  </reference>
  <reference>
    <citation>Sabel BA, Flammer J, Merabet LB. Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review. Restor Neurol Neurosci. 2018;36(6):767-791. doi: 10.3233/RNN-180880. Review.</citation>
    <PMID>30412515</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 3, 2019</study_first_submitted>
  <study_first_submitted_qc>July 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Magdeburg</investigator_affiliation>
    <investigator_full_name>Bernhard A. Sabel</investigator_full_name>
    <investigator_title>Head of Institute, Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The results will be available without restriction</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>After the results are published, unlimited duration</ipd_time_frame>
    <ipd_access_criteria>Contact to the principal investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

